Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 1
2010 1
2012 2
2013 3
2014 6
2015 7
2016 3
2017 3
2018 7
2019 6
2020 13
2021 13
2022 9
2023 8
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

78 results

Results by year

Filters applied: . Clear all
Page 1
CD39 and CD73 as Promising Therapeutic Targets: What Could Be the Limitations?
Battastini AMO, Figueiró F, Leal DBR, Doleski PH, Schetinger MRC. Battastini AMO, et al. Among authors: figueiro f. Front Pharmacol. 2021 Mar 11;12:633603. doi: 10.3389/fphar.2021.633603. eCollection 2021. Front Pharmacol. 2021. PMID: 33815115 Free PMC article. No abstract available.
Obesity drives adipose-derived stem cells into a senescent and dysfunctional phenotype associated with P38MAPK/NF-KB axis.
Grun LK, Maurmann RM, Scholl JN, Fogaça ME, Schmitz CRR, Dias CK, Gasparotto J, Padoin AV, Mottin CC, Klamt F, Figueiró F, Jones MH, Filippi-Chiela EC, Guma FCR, Barbé-Tuana FM. Grun LK, et al. Among authors: figueiro f. Immun Ageing. 2023 Oct 11;20(1):51. doi: 10.1186/s12979-023-00378-0. Immun Ageing. 2023. PMID: 37821967 Free PMC article.
Dysfunctional purinergic signaling correlates with disease severity in COVID-19 patients.
Pietrobon AJ, Andrejew R, Custódio RWA, Oliveira LM, Scholl JN, Teixeira FME, de Brito CA, Glaser T, Kazmierski J, Goffinet C, Turdo AC, Yendo T, Aoki V, Figueiró F, Battastini AM, Ulrich H, Benard G, Duarte AJDS, Sato MN. Pietrobon AJ, et al. Among authors: figueiro f. Front Immunol. 2022 Sep 30;13:1012027. doi: 10.3389/fimmu.2022.1012027. eCollection 2022. Front Immunol. 2022. PMID: 36248842 Free PMC article.
Characterization and antiproliferative activity of glioma-derived extracellular vesicles.
Scholl JN, de Fraga Dias A, Pizzato PR, Lopes DV, Moritz CEJ, Jandrey EHF, Souto GD, Colombo M, Rohden F, Sévigny J, Pohlmann AR, Guterres SS, Battastini AMO, Figueiró F. Scholl JN, et al. Among authors: figueiro f. Nanomedicine (Lond). 2020 Apr;15(10):1001-1018. doi: 10.2217/nnm-2019-0431. Epub 2020 Apr 6. Nanomedicine (Lond). 2020. PMID: 32249669
Development of bozepinib-loaded nanocapsules for nose-to-brain delivery: preclinical evaluation in glioblastoma.
Fraga Dias A, Dallemole DR, Bruinsmann FA, Lopes Silva LF, Cruz-López O, Conejo-García A, Oliveira Battastini AM, Campos JM, Guterres SS, Pohlmann AR, Figueiró F. Fraga Dias A, et al. Among authors: figueiro f. Nanomedicine (Lond). 2021 Oct;16(23):2095-2115. doi: 10.2217/nnm-2021-0164. Epub 2021 Sep 15. Nanomedicine (Lond). 2021. PMID: 34523353
EGFRvIII peptide nanocapsules and bevacizumab nanocapsules: a nose-to-brain multitarget approach against glioblastoma.
de Cristo Soares Alves A, Lavayen V, de Fraga Dias A, Bruinsmann FA, Scholl JN, Cé R, Visioli F, Oliveira Battastini AM, Stanisçuaski Guterres S, Figueiró F, Raffin Pohlmann A. de Cristo Soares Alves A, et al. Among authors: figueiro f. Nanomedicine (Lond). 2021 Aug;16(20):1775-1790. doi: 10.2217/nnm-2021-0169. Epub 2021 Jul 27. Nanomedicine (Lond). 2021. PMID: 34313137
78 results